Literature DB >> 18674841

Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells.

Xiong Ma1, Jing Hua, Zhiping Li.   

Abstract

BACKGROUND/AIMS: Dietary factors and intestinal bacteria play an important role in the rapidly increasing incidence of obesity and its associated conditions, such as steatosis and insulin resistance. In the current study, we evaluated the effect of probiotics, and their mechanisms on diet-induced obesity, steatosis and insulin resistance.
METHODS: Wild-type male C57BL6 mice were fed either normal or high fat diets. Some mice received VSL#3 probiotics. Animal weight, hepatic steatosis, insulin resistance, and their relationship to hepatic Natural Killer T cells (NKT) cell number and inflammatory signaling were evaluated.
RESULTS: High fat diet induced a depletion of hepatic NKT cells thus leading to insulin resistance and steatosis. Oral probiotic treatment significantly improved the high fat diet-induced hepatic NKT cell depletion, insulin resistance and hepatic steatosis. This effect was NKT cell dependant, resulted from the attenuation of the tumor necrosis factor-alpha and IkappaB kinase inflammatory signaling, and led to an improved sensitivity in insulin signaling.
CONCLUSIONS: Probiotics improve high fat diet-induced steatosis and insulin resistance. These effects of probiotics are likely due to increased hepatic NKT cell numbers and reduced inflammatory signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674841      PMCID: PMC2588670          DOI: 10.1016/j.jhep.2008.05.025

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  39 in total

1.  Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation.

Authors:  S Yang; H Lin; A M Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-08       Impact factor: 4.052

2.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

3.  Insulin signalling and the regulation of glucose and lipid metabolism.

Authors:  A R Saltiel; C R Kahn
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

4.  Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study.

Authors:  B Vessby; M Uusitupa; K Hermansen; G Riccardi; A A Rivellese; L C Tapsell; C Nälsén; L Berglund; A Louheranta; B M Rasmussen; G D Calvert; A Maffetone; E Pedersen; I B Gustafsson; L H Storlien
Journal:  Diabetologia       Date:  2001-03       Impact factor: 10.122

5.  Microbial ecology: human gut microbes associated with obesity.

Authors:  Ruth E Ley; Peter J Turnbaugh; Samuel Klein; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

6.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

7.  Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.

Authors:  M Yuan; N Konstantopoulos; J Lee; L Hansen; Z W Li; M Karin; S E Shoelson
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

8.  Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels.

Authors:  Eran Elinav; Orit Pappo; Miriam Sklair-Levy; Maya Margalit; Oren Shibolet; Moshe Gomori; Roslana Alper; Barbara Thalenfeld; Dean Engelhardt; Elazar Rabbani; Yaron Ilan
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

9.  Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice.

Authors:  Sou Ohkawara; Hideki Furuya; Kousuke Nagashima; Narito Asanuma; Tsuneo Hino
Journal:  J Nutr       Date:  2005-12       Impact factor: 4.798

10.  Metabolic endotoxemia initiates obesity and insulin resistance.

Authors:  Patrice D Cani; Jacques Amar; Miguel Angel Iglesias; Marjorie Poggi; Claude Knauf; Delphine Bastelica; Audrey M Neyrinck; Francesca Fava; Kieran M Tuohy; Chantal Chabo; Aurélie Waget; Evelyne Delmée; Béatrice Cousin; Thierry Sulpice; Bernard Chamontin; Jean Ferrières; Jean-François Tanti; Glenn R Gibson; Louis Casteilla; Nathalie M Delzenne; Marie Christine Alessi; Rémy Burcelin
Journal:  Diabetes       Date:  2007-04-24       Impact factor: 9.461

View more
  122 in total

Review 1.  Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.

Authors:  Tannaz Eslamparast; Sareh Eghtesad; Hossein Poustchi; Azita Hekmatdoost
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Galectin-9: Diverse roles in hepatic immune homeostasis and inflammation.

Authors:  Lucy Golden-Mason; Hugo R Rosen
Journal:  Hepatology       Date:  2017-05-27       Impact factor: 17.425

Review 3.  NKT cells in liver diseases.

Authors:  Shasha Zhu; Huimin Zhang; Li Bai
Journal:  Front Med       Date:  2018-04-06       Impact factor: 4.592

Review 4.  Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.

Authors:  Irina A Kirpich; Luis S Marsano; Craig J McClain
Journal:  Clin Biochem       Date:  2015-07-04       Impact factor: 3.281

Review 5.  Probiotics and gut health: a special focus on liver diseases.

Authors:  Silvia Wilson Gratz; Hannu Mykkanen; Hani S El-Nezami
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

6.  Probiotic antigens stimulate hepatic natural killer T cells.

Authors:  Shuwen Liang; Tonya Webb; Zhiping Li
Journal:  Immunology       Date:  2014-02       Impact factor: 7.397

Review 7.  Probiotics in hepatology.

Authors:  Jan Lata; Jana Jurankova; Marcela Kopacova; Petr Vitek
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

Review 8.  Dietary habits and behaviors associated with nonalcoholic fatty liver disease.

Authors:  Kenichiro Yasutake; Motoyuki Kohjima; Kazuhiro Kotoh; Manabu Nakashima; Makoto Nakamuta; Munechika Enjoji
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

9.  Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  F Higashikawa; M Noda; T Awaya; N Danshiitsoodol; Y Matoba; T Kumagai; M Sugiyama
Journal:  Eur J Clin Nutr       Date:  2016-03-09       Impact factor: 4.016

Review 10.  The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

Authors:  Luca Valenti; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Semin Immunopathol       Date:  2009-05-14       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.